Trial Profile
A Double-Blind, Randomized Multicenter, 3-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo and Salmeterol on Exercise-Induced Bronchoconstriction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary) ; Salmeterol (Primary)
- Indications Exercise-induced asthma
- Focus Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 22 Sep 2009 Actual initiation date changed from Aug 2006 to Jul 2006 as reported by ClinicalTrials.gov.
- 07 Feb 2009 New trial record